In this free webinar, learn how a multiplexed imaging platform can be used to determine mRNA capping and address mRNA vaccine drug product characterization requirements. Attendees will gain insights into rapidly measuring intact, capped and tailed mRNA in a single measurement to analyze mRNA intactness and percent capping efficiency. The featured speaker will discuss reducing downtime from outsourced liquid chromatography/mass spectroscopy (LC/MS) and capillary gel electrophoresis testing for determining these critical quality attributes. The speaker will also share insights into fit-for-purpose and in-process mRNA testing for all stages of vaccine development and mRNA manufacturing.
TORONTO, Sept. 30, 2024 /PRNewswire-PRWeb/ -- In recent years, the field of RNA-based vaccine products has grown rapidly. Methods for robust characterization of mRNA constructs and gene products have particularly lagged rapidly evolving research needs. InDevR's VaxArray® platform addresses many of these limitations providing solutions for simplifying and streamlining mRNA vaccine analytics.
The VaxArray platform is a benchtop fluorescence imaging device that is capable of measuring multiple critical attributes in a high-throughput format while being fully compliant with good manufacturing practice (GMP) requirements. For mRNA characterization, individual mRNA constructs can be identified along with the quantity, intactness and capping efficiency in less than 2 hours. For complete drug product characterization, the VaxArray platform can also assess levels of expressed protein in cell-based expression assays and characterize antibody responses in serological samples from clinical trials.
In this Webinar, Dr. Lacey will showcase the utility of the VaxArray platform throughout all stages of mRNA vaccine development. He will specifically focus on off-the-shelf assays for mRNA CQA characterization and protein expression while also highlighting the flexibility of the platform for custom assay development.
Register for this webinar today to understand how a multiplexed imaging platform can be used to determine mRNA capping and address mRNA vaccine drug product characterization requirements.
Join Randy Lacey, PhD, Field Applications Scientist, InDevR, for the live webinar on Thursday, October 17, 2024, at 12pm EDT (9am PDT).
For more information, or to register for this event, visit Measuring Intact mRNA and 5' Capping Efficiency in One Assay.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], https://xtalks.com
SOURCE Xtalks
Share this article